Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1985 of 5804
-
Can music or writing help heal healthcare Workers' trauma?
Symptom relief Recruiting nowIt is expected that large numbers of healthcare workers experience a broad range of psychological reactions and symptoms including anxiety, depression, moral distress, and trauma symptoms that will cause both significant suffering as well as occupational and social impairment. Th…
Phase: NA • Sponsor: Weill Medical College of Cornell University • Aim: Symptom relief
Last updated Jun 27, 2026 14:01 UTC
-
New laser tool may help doctors pinpoint lung nodules during biopsy
Diagnosis CompletedThis study is designed to evaluate the safety and feasibility of real-time needle-based confocal laser endomicroscopy (nCLE) in improving diagnostic accuracy of robotic-assisted bronchoscopy (RANB) biopsy performed with the Monarch® Endoscopy Platform in patients with peripheral …
Phase: NA • Sponsor: Johnson & Johnson Enterprise Innovation Inc. • Aim: Diagnosis
Last updated Jun 27, 2026 12:34 UTC
-
Mini tumors in a dish could pick the right drug for stubborn cancers
Knowledge-focused Recruiting now* PDOs are tridimensional multicellular structures expanded in vitro which retain the genotypic and phenotypic features of their tissue or tumor of origin. PDOs can be exposed to a panel of drugs (chemotherapy, hormonal therapy, targeted therapy) in order to study their sensitivi…
Phase: NA • Sponsor: Gustave Roussy, Cancer Campus, Grand Paris • Aim: Knowledge-focused
Last updated Jun 28, 2026 00:00 UTC
-
New immune globulin drug shows promise for rare nerve diseases in japan
Disease control CompletedThe main aim of the study is to check for side effects from TAK-771, and to check how well TAK-771 controls symptoms in Japanese participants with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) and multifocal motor neuropathy (MMN) The participants will be trea…
Phase: PHASE3 • Sponsor: Takeda • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
New drug XTX202 tested in patients with advanced cancers
Disease control CompletedA First-in-Human, Multicenter, Phase 1/2, Open-Label Study of XTX202 in Patients with Advanced Solid Tumors
Phase: PHASE1, PHASE2 • Sponsor: Xilio Development, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
AI matches doctors in reading mammograms for breast cancer
Diagnosis CompletedComparison of accuracy of clinician and DLAD image evaluation (Carebot AI MMG v2.2) 1. Comparison of the Accuracy of Density Assessment by Clinician and DLAD (DENS) 2. Comparison of Accuracy of Lesion Assessment by Clinician and DLAD (MASS, CLASS)
Sponsor: Carebot s.r.o. • Aim: Diagnosis
Last updated Jun 27, 2026 11:02 UTC
-
Scientists seek clues to personalize AL amyloidosis treatment
Knowledge-focused CompletedThrough an observational clinical study, partly prospective and partly retrospective, based on the collection of clinical data and on in vitro experimental analyses carried out on residual biological samples obtained during routine clinical procedures, it is proposed to identify …
Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:33 UTC
-
Can alternating feast and fast days beat daily dieting for lasting weight loss?
Disease control CompletedOne of the major challenges for treating obesity is to maintain a weight reduced state on the long term due to the high rate of weight regain. Therefore, the aim of this study is to evaluate the effects of an intermittent versus a continuous energy restriction in body composition…
Phase: NA • Sponsor: Universidade do Porto • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
School lunch makeover tested to fight obesity in rural kids
Prevention CompletedObesity is a significant cause of cancer and cardiovascular disease incidence and mortality, and diabetes incidence among rural communities. Arkansas has the sixth-highest proportion of rural population (\~41%),and has the third-highest obesity prevalence (37.4%) in the nation. A…
Phase: NA • Sponsor: University of Arkansas • Aim: Prevention
Last updated Jun 27, 2026 09:05 UTC
-
ALS drug trial halted early: what we know about oral edaravone
Disease control TerminatedTo evaluate and compare the efficacy of two dosing regimens of oral edaravone in subjects with amyotrophic lateral sclerosis (ALS), based on the time from the randomization date in Study MT-1186-A02 to at least a 12-point decrease in Revised ALS Functional Rating Score (ALSFRS-R)…
Phase: PHASE3 • Sponsor: Tanabe Pharma America, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Skin microbes linked to vitiligo and immunotherapy reactions in melanoma patients
Knowledge-focused TerminatedThe skin microbiome has been implicated in several cutaneous autoimmune pathologies such as psoriasis and atopic dermatitis. However, its role in vitiligo and vitiligo lesions occuring in patients receiving anti-PD-1 for metastatic melanoma
Phase: NA • Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
Exercise boosts quality of life in cancer patients, study finds
Symptom relief OngoingThis prospective observational cohort study evaluates a community-based supervised exercise oncology program delivered in real-world settings in Madrid, Spain. The program is designed for adults with a cancer diagnosis across the cancer continuum, including survivors, patients un…
Sponsor: University of Castilla-La Mancha • Aim: Symptom relief
Last updated Jun 27, 2026 08:14 UTC
-
Bone drug switch: can alendronate and zoledronate keep bones strong after denosumab?
Disease control CompletedThis study intends to investigate whether Alendronate and Zoledronate can prevent bone mineral density loss after long-term treatment with Denosumab.
Phase: PHASE4 • Sponsor: National Taiwan University Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Flickering light may boost brain function in Alzheimer's
Symptom relief CompletedThe investigator will investigate how light delivering 40 hertz (Hz) affects subjective sleep and cognition in a controlled laboratory study. A lab study will allow the collection of electroencephalogram (EEG) data, perform cognitive tests, and observe the response in those with …
Phase: NA • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Symptom relief
Last updated Jun 27, 2026 14:02 UTC
-
New eczema ointment shows promise in early trial
Symptom relief CompletedThis is a Phase I/II Study of MH004 in Healthy Adult Volunteers, participants with Mild to Moderate Atopic Dermatitis.
Phase: PHASE1, PHASE2 • Sponsor: Minghui Pharmaceutical (Hangzhou) Ltd • Aim: Symptom relief
Last updated Jun 26, 2026 19:16 UTC
-
New online tool helps rural parents struggling with opioids
Prevention CompletedOpioid use is rising at unprecedented levels and has reached epidemic proportions in some areas of the country, particularly rural areas. Although research on the detrimental effects of opioid use on parenting and children is relatively new, it is clear that parents with opioid u…
Phase: NA • Sponsor: University of Oregon • Aim: Prevention
Last updated Jun 27, 2026 09:00 UTC
-
Engineered immune cells take on Hard-to-Treat cancers
Disease control TerminatedIn this study, people with mesothelin-expressing advanced or metastatic solid tumors will receive TAK-103 with their white blood cells. The main aims of this study are to check if the participants get any side effects from treatment with TAK-103 and to check how much TAK-103 part…
Phase: PHASE1 • Sponsor: Takeda • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Second look inside the kidney: could repeat biopsies save lupus Patients' kidneys?
Knowledge-focused Recruiting nowLupus nephritis (LN) is one of the most severe complications of systemic lupus erythematosus (SLE). Among people living with SLE, 35-60% will develop LN during the course of the disease. This complication is one of the factors that contribute to deterioration of the renal functio…
Phase: NA • Sponsor: Karolinska Institutet • Aim: Knowledge-focused
Last updated Jun 26, 2026 12:53 UTC
-
Diabetes drug may fight heart scarring in High-Risk patients
Disease control CompletedRecently, large clinical intervention studies have demonstrated the cardiovascular protective effects on of sodium-glucose cotransporter 2 inhibitors (SGLT2i) such as empagliflozin, dapagliflozin, and canagliflozin in reduction of cardiovascular and all-cause mortality, coinciden…
Phase: PHASE4 • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Stitch showdown: can a simple change prevent hernias after liver surgery?
Prevention Recruiting nowThis clinical trial compares two different kinds of surgical closing techniques, short stitch suture or traditional suture, in patients who are having liver tumor surgery. This study may help researchers learn if one technique can lower the chances of developing a hole in the wal…
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Prevention
Last updated Jun 27, 2026 12:38 UTC